selected publications
- Morphologic and immunophenotypic characterization of lymphocytosis following BCMAtargeted CAR-T cell therapy in relapsed/refractory multiple myeloma. Haematologica. 2026 Academic Article GET IT
-
Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2025
Article
GET IT
Times cited: 3 -
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2025
Information Resource
GET IT
Times cited: 94 -
Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial.
Nature communications.
2025
Academic Article
GET IT
Times cited: 10 -
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma.
Blood advances.
2024
Academic Article
GET IT
Times cited: 21 - Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone. medRxiv : the preprint server for health sciences. 2024 Article GET IT
-
Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia.
Hematology/oncology clinics of North America.
2023
Information Resource
GET IT
Times cited: 1 -
Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia.
American journal of hematology.
2023
Article
GET IT
Times cited: 6 -
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.
Cancer cell.
2022
Academic Article
GET IT
Times cited: 50 -
Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance.
Frontiers in oncology.
2022
Information Resource
GET IT
Times cited: 10 -
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.
Nature communications.
2022
Academic Article
GET IT
Times cited: 30 -
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
The Lancet. Haematology.
2022
Academic Article
GET IT
Times cited: 66 -
Regular Aspirin Use and Mortality in Patients with Multiple Myeloma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
2021
Academic Article
GET IT
Times cited: 2 -
An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features.
Cancers.
2021
Information Resource
GET IT
Times cited: 5 -
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2021
Academic Article
GET IT
Times cited: 63 -
Placental extracellular vesicles-associated microRNA-519c mediates endotoxin adaptation in pregnancy.
American journal of obstetrics and gynecology.
2021
Academic Article
GET IT
Times cited: 23 -
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia.
Leukemia research.
2020
Academic Article
GET IT
Times cited: 26 -
Genome instability in multiple myeloma.
Leukemia.
2020
Information Resource
GET IT
Times cited: 88 -
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.
Nature communications.
2020
Academic Article
GET IT
Times cited: 156 -
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Academic Article
GET IT
Times cited: 166 -
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma.
Nature cancer.
2020
Academic Article
GET IT
Times cited: 303 -
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Information Resource
GET IT
Times cited: 149 - Reply to F.D. Leonard. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Article GET IT
-
Bone marrow niche in multiple myeloma and its precursor states.
HemaSphere.
2019
Academic Article
GET IT
Times cited: 3 -
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2019
Academic Article
GET IT
Times cited: 87 -
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group.
American journal of hematology.
2019
Article
GET IT
Times cited: 12 -
Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients.
Blood.
2018
Article
GET IT
Times cited: 33 -
Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia.
PloS one.
2018
Academic Article
GET IT
Times cited: 20 -
Advancements in Nanomedicine for Multiple Myeloma.
Trends in molecular medicine.
2018
Information Resource
GET IT
Times cited: 27 -
Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.
The Journal of clinical investigation.
2018
Academic Article
GET IT
Times cited: 103 -
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.
Nature communications.
2018
Academic Article
GET IT
Times cited: 179 -
A Rare Case of Composite Dural Extranodal Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Frontiers in neurology.
2018
Information Resource
GET IT
Times cited: 21 -
Established and Novel Prognostic Biomarkers in Multiple Myeloma.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
2017
Information Resource
GET IT
Times cited: 32 -
Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.
Neoplasia (New York, N.Y.).
2016
Academic Article
GET IT
Times cited: 34 -
Traumatic brain injury and subsequent glioblastoma development: Review of the literature and case reports.
Surgical neurology international.
2016
Academic Article
GET IT
Times cited: 31 -
Adult Primary Spinal Epidural Extraosseous Ewing's Sarcoma: A Case Report and Review of the Literature.
Case reports in neurological medicine.
2016
Article
GET IT
Times cited: 3